- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 69
Kronos Bio casts IPO range
MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.
Oct 7, 2020Kronos Bio casts IPO range
GV is in line for an exit as the cancer therapy developer set terms for an offering that will raise more than $185m if it floats at the top of its range.
Oct 7, 2020Kiyo Learning gets IPO qualification
The online employee and further education provider is set to list on TSE’s Mothers Market, allowing Freebit, Matching Service Japan, MyNavi and Will Group to exit.
Oct 7, 2020Deliveroo develops 2021 IPO plan
The food delivery service reportedly expects to achieve a valuation of more than $2.6bn when it floats, having secured permission for Amazon to invest earlier this year.
Oct 6, 2020C4 Therapeutics blows on to public markets
Dana-Farber Cancer Institute's cancer therapy developer raised $182m in an upsized IPO where it floated above its range.
Oct 5, 2020Ozon opens up to IPO possibilities
The Sistema-backed e-commerce marketplace has confidentially filed for an initial public offering in the US that would value it at $3bn to $5bn.
Oct 5, 2020Roblox to roll to IPO
Tencent-backed online gaming platform developer Roblox is in talks over an IPO or direct listing at a valuation of up to $8bn.
Oct 5, 2020C4 Therapeutics blows on to public markets
The Roche, Novartis and Kraft Group-backed cancer therapy developer raised $182m in an upsized IPO where it floated above its range.
Oct 5, 2020Palantir joins NYSE limelight
Sompo, Fujitsu and Relx-backed Palantir went public yesterday and fetched a $20.6bn valuation – only marginally above the $20.3bn it was worth in 2015.
Oct 1, 2020McAfee to return to stock market
The cybersecurity company was once listed on NYSE, before an acquisition by Intel and a subsequent spinoff, and has now put a $100m placeholder figure on its planned IPO.
Sep 30, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


